Loss of heterozygosity on the long arm of chromosome 22 in pheochromocytoma

Genes Chromosomes Cancer. 1992 Nov;5(4):399-403. doi: 10.1002/gcc.2870050416.

Abstract

To identify the putative common deleted region on the long arm of chromosome 22 in pheochromocytoma, restriction fragment length polymorphism analysis was performed in 17 pheochromocytomas. All cases were heterozygous for at least one of the eight marker loci on 22q. Loss of heterozygosity (LOH) was observed in nine pheochromocytomas, of which eight were hereditary and one nonhereditary. Three pheochromocytomas had interstitial deletions that enabled us to localize the commonly deleted region as distal to D22S10 and proximal to D22S22. Hereditary pheochromocytoma frequently occurs in association with medullary thyroid carcinoma (MTC). Therefore, we also studied allelic loss on 22q in 23 hereditary MTCs. Only one of the MTCs showed LOH on 22q. Recent studies have mapped tumor suppressor loci associated with meningioma and neurofibromatosis type 2 (NF2) to 22q. The commonly deleted region in pheochromocytoma found by us encompasses the regions to which tumor suppressor genes associated with NF2 and meningioma have been mapped. The exact role of the pheochromocytoma tumor suppressor gene on 22q and its relationship to the suppressor genes involved in NF2 and meningioma remain unknown.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Gland Neoplasms / blood
  • Adrenal Gland Neoplasms / genetics*
  • Adrenal Gland Neoplasms / pathology
  • Alleles
  • Carcinoma / genetics
  • Carcinoma / pathology
  • Chromosome Aberrations*
  • Chromosomes, Human, Pair 22 / ultrastructure*
  • DNA Probes
  • Gene Deletion*
  • Genes, Neurofibromatosis 2
  • Genes, Tumor Suppressor*
  • Genetic Markers
  • Humans
  • Meningeal Neoplasms / genetics
  • Meningioma / genetics
  • Multiple Endocrine Neoplasia / genetics
  • Multiple Endocrine Neoplasia / pathology
  • Neurofibromatosis 2 / genetics
  • Pheochromocytoma / blood
  • Pheochromocytoma / genetics*
  • Pheochromocytoma / pathology
  • Polymorphism, Restriction Fragment Length*
  • Thyroid Neoplasms / genetics
  • Thyroid Neoplasms / pathology

Substances

  • DNA Probes
  • Genetic Markers